The Perrigo Company (NASDAQ: PRGO) announced today the appointment by the Board of Directors of Gary K. Kunkle, Jr. as a new director of the Company. Mr. Kunkle was appointed to fill a vacancy and will serve for a three-year term expiring on the date of the annual meeting in 2005.
In making the announcement, Perrigo President and Chief Executive Officer, David T. Gibbons, said, "Gary Kunkle has an outstanding background in the health care industry and his broad business knowledge, managerial experience and executive leadership will enable him to play a significant role as a member of the Perrigo Board. We are pleased to welcome Gary to the Perrigo team."
Mr. Kunkle, 55, is President and Chief Operating Officer and a member of the Board of Directors of DENTSPLY International Inc. (NASDAQ: XRAY), the world's leading manufacturer of professional dental products. He joined DENTSPLY in 1997, after serving as President of Johnson & Johnson Vistakon and President of Johnson & Johnson Orthopedics in his 25-year career with Johnson & Johnson.
Perrigo Company is the nation's largest manufacturer of over-the-counter (non-prescription) pharmaceutical and nutritional products sold by supermarket, drug, and mass merchandise chains under their own labels. The Company's products include over-the-counter pharmaceuticals such as analgesics, cough and cold remedies, gastrointestinal, and feminine hygiene products, and nutritional products, such as vitamins, nutritional supplements and nutritional drinks. Visit Perrigo on the Internet (www.perrigo.com ).
SOURCE: Perrigo Company
CONTACT: Ernest J. Schenk, Manager, Investor Relations and Communication
of Perrigo Company, +1-269-673-9212, or E-mail: Investor@perrigo.com
Web site: http://www.perrigo.com/
Company News On-Call: http://www.prnewswire.com/comp/699550.html